Vivos

#药闻简讯# $Vivos(VVOS)$ Therapeutics 发布儿童阻塞性睡眠呼吸暂停症里程碑式临床试验结果

$Vivos(VVOS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001641172-25-024979  Act: 34  Size: 299 KB 网页链接

$Vivos(VVOS)$ 8-K/A [Amend] Current report, items 2.01, 8.01, and 9.01 Accession Number: 0001641172-25-025396  Act: 34  Size: 918 KB 网页链接

$Vivos(VVOS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-024832  Act: 34  Size: 6 MB 网页链接

$Vivos(VVOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002902  Act: 33  Size: 1 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-013953  Act: 34  Size: 238 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-027210  Act: 34  Size: 490 KB 网页链接

$Vivos(VVOS)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001641172-25-024033  Act: 34  Size: 31 KB 网页链接

$Vivos(VVOS)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001641172-25-027207  Act: 33  Size: 595 KB 网页链接

$Vivos(VVOS)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001641172-25-026733  Act: 33  Size: 415 KB 网页链接

$Vivos(VVOS)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-25-015837  Act: 34  Size: 8 MB 网页链接